Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Matthijs W. van Hoogdalem, Brooks T. McPhail, David Hahn, Scott L. Wexelblatt, Henry T. Akinbi, Alexander A. Vinks & Tomoyuki Mizuno. (2021) Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics. Expert Opinion on Drug Metabolism & Toxicology 17:1, pages 87-103.
Read now
Read now
Ish K Khanna & Sivaram Pillarisetti. (2015) Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain. Journal of Pain Research 8, pages 859-870.
Read now
Read now
J. Karlsson, A. Söderström, B.G. Augustini & A.C. Berggren. (2014) Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study. Current Medical Research and Opinion 30:4, pages 575-587.
Read now
Read now
DonaldR. Wesson & DavidE. Smith. (2010) Buprenorphine in the Treatment of Opiate Dependence. Journal of Psychoactive Drugs 42:2, pages 161-175.
Read now
Read now
Nalini Vadivelu & Roberta L Hines. (2008) Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clinical Interventions in Aging 3:3, pages 421-430.
Read now
Read now
DonaldR. Wesson. (2004) Buprenorphine in the Treatment of Opiate Dependence: Its Pharmacology and Social Context of Use in the U.S.. Journal of Psychoactive Drugs 36:sup2, pages 119-128.
Read now
Read now
R. B. Pontani, N. L. Vadlamani & A. L. Misra. (1985) Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant. Xenobiotica 15:4, pages 287-297.
Read now
Read now
Articles from other publishers (62)
Kimberly S. Ryan, Kristin C. Prewitt, Sarena Hayer, Madeline A. Hedges, Ashley E. Benson & Jamie O. Lo. (2023) Opioid Use in Pregnancy: A Review. Obstetrical & Gynecological Survey 78:1, pages 35-49.
Crossref
Crossref
Terrence P. Clark. (2022) The history and pharmacology of buprenorphine: New advances in cats. Journal of Veterinary Pharmacology and Therapeutics 45:S1.
Crossref
Crossref
Kanse Apeksha S., Kanase Jyoti A., Chaugule Ashiya M., Gosavi Akshata A. & Kolekar Utkarsha U.. (2022) Role of Buprenophine in Chronic Pain Management in Covid-19. International Journal of Advanced Research in Science, Communication and Technology, pages 818-822.
Crossref
Crossref
Matthijs W. van Hoogdalem, Scott L. Wexelblatt, Henry T. Akinbi, Alexander A. Vinks & Tomoyuki Mizuno. (2022) A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. Pharmacology & Therapeutics 234, pages 108045.
Crossref
Crossref
Matthijs W. van Hoogdalem, Trevor N. Johnson, Brooks T. McPhail, Suyog Kamatkar, Scott L. Wexelblatt, Laura P. Ward, Uwe Christians, Henry T. Akinbi, Alexander A. Vinks & Tomoyuki Mizuno. (2021) Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome. Clinical Pharmacology & Therapeutics 111:2, pages 496-508.
Crossref
Crossref
Albert Lin & Anuj Aggarwal. 2022. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics
55
61
.
Ilkka Ojanperä, Claudia Mariottini & Pirkko Kriikku. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
2863
2882
.
Ilkka Ojanperä, Claudia Mariottini & Pirkko Kriikku. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
20
.
Garima Sharma, Madhusudhan Alle, Chiranjib Chakraborty & Jin-Chul Kim. (2021) Strategies for transdermal drug delivery against bone disorders: A preclinical and clinical update. Journal of Controlled Release 336, pages 375-395.
Crossref
Crossref
Jeffrey Gudin & Jeffrey Fudin. (2020) A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain. Pain and Therapy 9:1, pages 41-54.
Crossref
Crossref
Mari Fihlman, Tuija Hemmilä, Nora M. Hagelberg, Janne T. Backman, Jouko Laitila, Kari Laine, Pertti J Neuvonen, Klaus T. Olkkola & Teijo I. Saari. (2018) Voriconazole greatly increases the exposure to oral buprenorphine. European Journal of Clinical Pharmacology 74:12, pages 1615-1622.
Crossref
Crossref
Mellar P. Davis, Gavril Pasternak & Bertrand Behm. (2018) Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 78:12, pages 1211-1228.
Crossref
Crossref
R. J. Johnson, C. L. Kerr, S. S. Enouri, P. Modi, B. D. X. Lascelles & J. R. E. del Castillo. (2017) Pharmacokinetics of liposomal encapsulated buprenorphine suspension following subcutaneous administration to cats. Journal of Veterinary Pharmacology and Therapeutics 40:3, pages 256-269.
Crossref
Crossref
Neha V. Maharao, Anand A. Joshi & Phillip M. Gerk. (2017)
Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements:
in vitro
proof of concept
. Biopharmaceutics & Drug Disposition 38:2, pages 139-154.
Crossref
Crossref
Anand Joshi, Matthew Halquist, Zacharoula Konsoula, Yongzhen Liu, J P Jones, Christian Heidbreder & Phillip M Gerk. (2017)
Improving the oral bioavailability of buprenorphine: an
in-vivo
proof of concept
. Journal of Pharmacy and Pharmacology 69:1, pages 23-31.
Crossref
Crossref
Nora M. Hagelberg, Mari Fihlman, Tuija Hemmilä, Janne T. Backman, Jouko Laitila, Pertti J. Neuvonen, Kari Laine, Klaus T. Olkkola & Teijo I. Saari. (2016) Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects. Pharmacology Research & Perspectives 4:6.
Crossref
Crossref
Mari Fihlman, Tuija Hemmilä, Nora M. Hagelberg, Kristiina Kuusniemi, Janne T. Backman, Jouko Laitila, Kari Laine, Pertti J. Neuvonen, Klaus T. Olkkola & Teijo I. Saari. (2016) Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction. European Journal of Clinical Pharmacology 72:11, pages 1363-1371.
Crossref
Crossref
Lin Xu. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
3
.
Robert TaylorJr.Jr., Robert B. Raffa & Joseph V. PergolizziJr.Jr.. 2013. Handbook of Methadone Prescribing and Buprenorphine Therapy. Handbook of Methadone Prescribing and Buprenorphine Therapy
183
200
.
Mellar P. Davis. (2012) Twelve Reasons for Considering Buprenorphine as a Frontline Analgesic in the Management of Pain. The Journal of Supportive Oncology 10:6, pages 209-219.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
514
526
.
Margareeta Häkkinen, Terhi Launiainen, Erkki Vuori & Ilkka Ojanperä. (2011) Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning. European Journal of Clinical Pharmacology 68:3, pages 301-309.
Crossref
Crossref
Takako Furukawa, Fumihiro Nakamori, Kazuhiro Tetsuka, Yoichi Naritomi, Hiroyuki Moriguchi, Katsuhiro Yamano, Shigeyuki Terashita & Toshio Teramura. (2012) Quantitative Prediction of Intestinal Glucuronidation of Drugs in Rats Using In Vitro Metabolic Clearance Data. Drug Metabolism and Pharmacokinetics 27:2, pages 171-180.
Crossref
Crossref
DAVID BREWSTER, MICHAEL J HUMPHREY & MICHAEL A MCLEAVY. (1981) The systemic bioavailability of buprenorphine by various routes of administration. Journal of Pharmacy and Pharmacology 33:1, pages 500-506.
Crossref
Crossref
Craig Mosley. (2011) Pain and Nociception in Reptiles. Veterinary Clinics of North America: Exotic Animal Practice 14:1, pages 45-60.
Crossref
Crossref
Neal M. Davies, Jody K. Takemoto, Dion R. Brocks & Jaime A. Yáñez. (2010) Multiple Peaking Phenomena in Pharmacokinetic Disposition. Clinical Pharmacokinetics 49:6, pages 351-377.
Crossref
Crossref
Lisa H Xie, Qigui Li, Jing Zhang & Peter J Weina. (2009) Pharmacokinetics, tissue distribution and mass balance of radiolabeled dihydroartemisinin in male rats. Malaria Journal 8:1.
Crossref
Crossref
Giustino Varrassi, Chiara Angeletti, Cristiana Guetti, Franco Marinangeli & Antonella Paladini. (2009) Systemic opioid and chronic pain. European Journal of Pain Supplements 3:S2, pages 77-83.
Crossref
Crossref
Hans G. Kress. (2009) Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. European Journal of Pain 13:3, pages 219-230.
Crossref
Crossref
Qigui Li, Lisa Xie, Jing Zhang & Peter J. Weina. (2008) The distribution pattern of intravenous [14C] artesunate in rat tissues by quantitative whole-body autoradiography and tissue dissection techniques. Journal of Pharmaceutical and Biomedical Analysis 48:3, pages 876-884.
Crossref
Crossref
Monica Escher, Youssef Daali, Jocelyne Chabert, Gérard Hopfgartner, Pierre Dayer & Jules Desmeules. (2007) Pharmacokinetic and Pharmacodynamic Properties of Buprenorphine After a Single Intravenous Administration in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Clinical Therapeutics 29:8, pages 1620-1631.
Crossref
Crossref
David RP Guay. (2006) Opioid analgesics for persistent pain in the older patient. Aging Health 2:4, pages 669-690.
Crossref
Crossref
Yan Chang, David E. Moody & Elinore F. McCance-Katz. (2006) NOVEL METABOLITES OF BUPRENORPHINE DETECTED IN HUMAN LIVER MICROSOMES AND HUMAN URINE. Drug Metabolism and Disposition 34:3, pages 440-448.
Crossref
Crossref
Domenic A. Ciraulo, Robert J. Hitzemann, Eugene Somoza, Clifford M. Knapp, John Rotrosen, Ofra Sarid-Segal, Ann Marie Ciraulo, David J. Greenblatt & C. Nora Chiang. (2006) Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials. The Journal of Clinical Pharmacology 46:2, pages 179-192.
Crossref
Crossref
Nicolas Picard, Thierry Cresteil, Nassim Djebli & Pierre Marquet. (2005) IN VITRO METABOLISM STUDY OF BUPRENORPHINE: EVIDENCE FOR NEW METABOLIC PATHWAYS. Drug Metabolism and Disposition 33:5, pages 689-695.
Crossref
Crossref
Rolley E. Johnson, Paul J. Fudala & Richard Payne. (2005) Buprenorphine: Considerations for Pain Management. Journal of Pain and Symptom Management 29:3, pages 297-326.
Crossref
Crossref
Yan Chang & David E. Moody. (2005) Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes. European Journal of Clinical Pharmacology 60:12, pages 875-881.
Crossref
Crossref
Alexander Elkader & Beth Sproule. (2005) Buprenorphine. Clinical Pharmacokinetics 44:7, pages 661-680.
Crossref
Crossref
R Vanbinst, J Koenig, V Di Fazio & A Hassoun. (2002) Bile analysis of drugs in postmortem cases. Forensic Science International 128:1-2, pages 35-40.
Crossref
Crossref
David E. Moody, Matthew H. Slawson, Eric C. Strain, John D. Laycock, Alan C. Spanbauer & Rodger L. Foltz. (2002) A Liquid Chromatographic-Electrospray Ionization-Tandem Mass Spectrometric Method for Determination of Buprenorphine, Its Metabolite, norBuprenorphine, and a Coformulant, Naloxone, That Is Suitable for in Vivo and in Vitro Metabolism Studies. Analytical Biochemistry 306:1, pages 31-39.
Crossref
Crossref
Aldo Polettini & Marilyn A Huestis. (2001) Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine–glucuronide in plasma by liquid chromatography–tandem mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications 754:2, pages 447-459.
Crossref
Crossref
Sumithra Gopal, Tsang-Bin Tzeng & Alan Cowan. (2001) Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma. European Journal of Pharmaceutics and Biopharmaceutics 51:2, pages 147-151.
Crossref
Crossref
J. M. GaulierP. MarquetE. LacassieJ. L. DupuyG. Lachatre. (2000) Fatal Intoxication Following Self-Administration of a Massive Dose of Buprenorphine. Journal of Forensic Sciences 45:1, pages 14667J.
Crossref
Crossref
Rajneesh P. Nath, Robert A. Upton, E. Thomas Everhart, Polly Cheung, Peter Shwonek, Reese T. Jones & John E. Mendelson. (2013) Buprenorphine Pharmacokinetics: Relative Bioavailability of Sublingual Tablet and Liquid Formulations. The Journal of Clinical Pharmacology 39:6, pages 619-623.
Crossref
Crossref
Diana G. Wilkins, Angelique S. Valdez, Pamela R. Nagasawa, Steven P. Gygi & Douglas E. Rollins. (1998) Incorporation of Drugs for the Treatment of Substance Abuse into Pigmented and Nonpigmented Hair. Journal of Pharmaceutical Sciences 87:4, pages 435-440.
Crossref
Crossref
B. Widdop. 1997. Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists. Analytical Toxicology for Clinical, Forensic and Pharmaceutical Chemists
509
542
.
Abdallah Salem, Tracie L. Pierce & Wendy Hope. (1997) Analysis of buprenorphine in rat plasma using a solid-phase extraction technique and high-performance liquid chromatography with electrochemical detection. Journal of Pharmacological and Toxicological Methods 37:2, pages 75-81.
Crossref
Crossref
Kazunori Watanabe, Shigeru Yakou, Kozo Takayama, Koichi Isowa & Tsuneji Nagai. (1996) Rectal absorption and mucosal irritation of rectal gels containing buprenorphine hydrochloride prepared with water-soluble dietary fibers, xanthan gum and locust bean gum. Journal of Controlled Release 38:1, pages 29-37.
Crossref
Crossref
Mary F. Kanz, Aixia Wang & Gerald A. Campbell. (1995) Infusion of bile from methylene dianiline-treated rats into the common bile duct injures biliary epithelial cells of recipient rats. Toxicology Letters 78:2, pages 165-171.
Crossref
Crossref
K. A. Lehmann. 1994. Der postoperative Schmerz. Der postoperative Schmerz
270
286
.
J.P. Cassidy, N.M. Landzert & E. Quadros. (1993) Controlled buccal delivery of buprenorphine. Journal of Controlled Release 25:1-2, pages 21-29.
Crossref
Crossref
Edward R. Garrett & V. Ravi Chandran. (2006) Pharmacokinetics of morphine and its surrogates X: Analyses and pharmacokinetics of buprenorphine in dogs. Biopharmaceutics & Drug Disposition 11:4, pages 311-350.
Crossref
Crossref
K. A. Lehmann. 1990. Der postoperative Schmerz. Der postoperative Schmerz
201
214
.
G.L. LARSEN. 1988. Role of the Gut Flora in Toxicity and Cancer. Role of the Gut Flora in Toxicity and Cancer
79
107
.
H. Kijewski, H. Kampmann, G. Remberg & A. Eggert. 1988. Suchtkrankheiten. Suchtkrankheiten
202
205
.
R.A. Moore, C.W. Hand & H.J. McQuay. (1987) Opiate metabolism and excretion. Baillière's Clinical Anaesthesiology 1:4, pages 829-858.
Crossref
Crossref
C W Hand, D Baldwin, R A Moore, M C Allen & H J McQuay. (2016) Radioimmunoassay of Buprenorphine with Iodine Label: Analysis of Buprenorphine and Metabolites in Human Plasma. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 23:1, pages 47-53.
Crossref
Crossref
S.J. Castle, G.T. Tucker, H.F. Woods, J.C.E. Underwood, C.M. Nicholson, M.E. Havler, C.J. Lewis, I.R. Flockhart & G. Lloyd-Jones. (1985) Assessment of an in situ rat intestine preparation with perfused vascular bed for studying the absorption and first-pass metabolism of drugs. Journal of Pharmacological Methods 14:4, pages 255-274.
Crossref
Crossref
Ylva Blom, Ulf Bondesson & Erik Änggård. (1985) Analysis of buprenorphine and its n-dealkylated metabolite in plasma and urine by selected-ion monitoring. Journal of Chromatography B: Biomedical Sciences and Applications 338, pages 89-98.
Crossref
Crossref
Edward J. Cone, Charles W. Gorodetzky, David Yousefnejad & William D. Darwin. (1985) 63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. Journal of Chromatography B: Biomedical Sciences and Applications 337, pages 291-300.
Crossref
Crossref
Robert S. Pearlman, Gerald J. Yakatan & Robert J. Wills. (1984) Effect of Nonuniform Bile Flow Rate on the Rate of Biliary Excretion of Bromophenol Blue in the Beagle. Journal of Pharmaceutical Sciences 73:7, pages 932-935.
Crossref
Crossref
Francis L.S. Tse, Frances Ballard & James M. Jaffe. (1982) A practical method for monitoring drug excretion and enterohepatic circulation in the rat. Journal of Pharmacological Methods 7:2, pages 139-144.
Crossref
Crossref